Lead Product(s): SKY01
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: French Tech Seed
Deal Size: $0.8 million Upfront Cash: Undisclosed
Deal Type: Funding January 20, 2020
These funds will allow the company to accelerate the development of its flagship drug candidate, before launching a new fundraising round that will address clinical trials.